Phenocell and Amarna Therapeutics Awarded Eurostars Grant to Assess a Gene Therapy for Dry AMD using a novel 3-dimensional iPSC-derived Retinal Model of the Disease
December 11, 2024 09:07 ET
|
Amarna Therapeutics
Grasse, France and Leiden, the Netherlands – 11 December 2024 – Phenocell SAS (part of Axol Bioscience) a leading provider of stem cell-derived models and services, and Amarna Therapeutics, a...
Former Merck USA President Joins Klotho Neurosciences’ Board of Directors
December 03, 2024 11:00 ET
|
Klotho Neurosciences, Inc.
Former Merck USA President Joins Klotho Neurosciences’ Board of Directors
Dr. Makoto Kuro-o, Pioneer of the Klotho Anti-Aging Gene, Joins Klotho Neurosciences, Inc. as Scientific Advisor
October 23, 2024 06:00 ET
|
Klotho Neurosciences, Inc.
Dr. Makoto Kuro-o, Pioneer of the Klotho Anti-Aging Gene, Joins Klotho Neurosciences, Inc. as Scientific Advisor
US Retinal Specialists Highlight the Greatest Opportunity for Gene Therapies
March 19, 2024 14:20 ET
|
Spherix Global Insights
EXTON, PA, March 19, 2024 (GLOBE NEWSWIRE) -- Gene therapies have emerged as a ray of hope, particularly in the realm of eye diseases. The focus on the eye has provided researchers with a promising...
Gene Therapies In Ophthalmology Clinical Trial Pipeline Appears Robust With 55+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
February 19, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Feb. 19, 2024 (GLOBE NEWSWIRE) -- Gene Therapies In Ophthalmology Clinical Trial Pipeline Appears Robust With 55+ Key Pharma Companies Actively Working in the Therapeutics Segment |...
Parkinson’s Disease Patient Identification and Education Will Need to Improve When New Disease Modifying Therapies Are Approved, According to Spherix Global Insights
February 16, 2024 10:40 ET
|
Spherix Global Insights
EXTON, PA, Feb. 16, 2024 (GLOBE NEWSWIRE) -- Millions of people worldwide are affected by Parkinson’s disease (PD), prompting the need for effective disease-modifying therapies (DMTs) to target this...
Gene Switch/Molecular Switch Market projected to reach USD 1.4 Billion by 2030, growing at a CAGR of 11.3% during the forecast period of 2023-2030 - pronounced by MarketDigits in its recent study
February 15, 2024 08:00 ET
|
PIONEERING MARKETDIGITS CONSULTING AND ADVISORY PRIVATE LIMITED
Richmond, Feb. 15, 2024 (GLOBE NEWSWIRE) -- According to a research report "Gene Switch/Molecular Switch Market”, by Product Type (CAR-T Cell Therapies, Gene Therapies, Others), Payment model...
Rentschler Biopharma joins forces with Ikarovec to accelerate novel gene therapies for treatment of ophthalmic disease
June 01, 2023 05:09 ET
|
Rentschler Biopharma SE
Rentschler Biopharma to conduct adeno-associated virus (AAV) process development work for manufacturing scale-up at their ATMP site in Stevenage, UKIkarovec is developing novel gene therapies to treat...
Novartis shares Zolgensma long-term data demonstrating sustained durability up to 7.5 years post-dosing; 100% achievement of all assessed milestones in children treated prior to SMA symptom onset
March 19, 2023 19:00 ET
|
Novartis Pharma AG
Children in LT-001 treated after SMA symptom onset maintained or achieved additional milestones up to 7.5 years post one-time intravenous infusionAll children (100%) in the presymptomatic intravenous...
Regenerative Medicine Market is Expected to Reach $40.6 Billion | MarketsandMarkets.
February 24, 2023 07:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, Feb. 24, 2023 (GLOBE NEWSWIRE) -- Regenerative medicine is an emerging field of medicine that is focused on using the body’s natural healing processes to repair and regenerate damaged...